Literature DB >> 26079395

Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?

Karl Z Lukic1, Allan L Coates1,2.   

Abstract

While the FEV1 had been recognized as an excellent indicator of disability, it is not very sensitive to early and mild disease. In cystic fibrosis (CF) small airway disease is believed to be one of the early hallmarks and indices such as the FEF25-75 and FEF75 have been proposed as sensitive markers of early disease. The site of early disease in asthma is not as well worked out. Recently a study of more than 20,000 spirometries found that neither of these indices added anything to the FEV1 /FVC but that study was not disease specific and contained both adults and children and the adults were the most numerous. To see if this would be true in children, 1,175 spirograms from children 6 to 18 years of age with CF or asthma whose FEV1 and FVC were above the lower limit of normal were taken from sequential studies. The data expressed in z scores was plotted with either the FEF25-75 or FEF75 plotted against FEV1 /FVC. In both diseases, but particularly in asthma, the FEV1 /FVC was more likely to be abnormal than either of the other two indices for suggesting that for children, early, or mild disease will be more apparent using the FEV1 /FVC than any other index.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FEF25-75; FEF75; FEV1/FVC; asthma; cystic fibrosis; global lung initiative; spirometry

Mesh:

Year:  2015        PMID: 26079395     DOI: 10.1002/ppul.23234

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

2.  Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values.

Authors:  Angela Zacharasiewicz; Sabine Renner; Flora Haderer; Michael Weber; Eleonore Dehlink; Zsolt Szepfalusi; Thomas Frischer
Journal:  Wien Klin Wochenschr       Date:  2017-03-09       Impact factor: 1.704

3.  Pattern of Lung Function Is Not Associated with Prior or Future Morbidity in Children with Sickle Cell Anemia.

Authors:  Robyn T Cohen; Robert C Strunk; Mark Rodeghier; Carol L Rosen; Fenella Jane Kirkham; Jane Kirkby; Michael R DeBaun
Journal:  Ann Am Thorac Soc       Date:  2016-08

4.  Longitudinal changes in lung function in very prematurely born young people receiving high-frequency oscillation or conventional ventilation from birth.

Authors:  Alessandra Bisquera; Christopher Harris; Alan Lunt; Sanja Zivanovic; Neil Marlow; Sandy Calvert; Anne Greenough; Janet L Peacock
Journal:  Pediatr Pulmonol       Date:  2022-04-18

5.  Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Authors:  Arthur F Gelb; Alfred Yamamoto; Eric K Verbeken; James C Hogg; Donald P Tashkin; Diem N T Tran; Roxanna M Moridzadeh; Christine Fraser; Mark J Schein; Marc Decramer; Eric F Glassy; Jay A Nadel
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

6.  The Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study.

Authors:  Aarti Shakkottai; Samya Z Nasr
Journal:  Glob Pediatr Health       Date:  2017-02-02

7.  Childhood lung function following perinatal HIV infection and early antiretroviral therapy initiation: a cross-sectional study.

Authors:  Andre Gie; Julie Morrison; David Maree; Barbara Laughton; Sara H Browne; Mark F Cotton; Pierre Goussard; Steve Innes
Journal:  ERJ Open Res       Date:  2022-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.